Biotech Fluidics launches the compact mikron 91 pH probe for accurate inline measurement in chromatography and bioprocessing.

Phylloceuticals has produced its first plant-based PD-1 inhibitor monoclonal antibody only 12 weeks after launching operations in Rapid City, SD.

Phylloceuticals has appointed Nick Casale to its Board of Directors. With over 30 years in biotech engineering and operations, Casale brings expertise from roles at Ultragenyx, Novartis, Biogen and more.

Bio-Rad has introduced four new Droplet Digital PCR platforms, including the QX Continuum™ and QX700™ series. These additions enhance Bio-Rad’s ddPCR offerings with simplified workflows, advanced multiplexing and high throughput.

TESTA’s viscometer boosts GPC/SEC sensitivity, enabling low-flow, low-concentration and semi-micro applications.

Amsbio launches GMP-grade enzymes for tissue dissociation, supporting stem cell and regenerative medicine workflows.

Xcell Biosciences collaborates with Thermo Fisher to advance Treg and TIL therapies for autoimmune and solid tumor diseases.

Biotech Fluidics opens a new office in Germany to support the DACH region with innovative fluidic system solutions.

Abcore® announces the launch of AbNano™ Anti-T-Cell VHH Library, a first-in-class, naturally-derived VHH library designed for the rapid identification of antibodies that bind to native T-cell surface proteins.

Refeyn has announced that mass photometry has been recognized by the US Pharmacopeia (USP) as a key orthogonal method for characterizing USP’s new AAV reference standards.